We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Breakthrough Therapy

News List

Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib americanpharmaceuticalreview
December 19, 2018
Eiger BioPharmaceuticals announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for lonafarnib for the treatment of hepatitis delta virus (HDV) infection......
FDA Grants Breakthrough Therapy Designation for Xolair americanpharmaceuticalreview
August 14, 2018
Genentech announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions following accidental exposure to one or more foods in people with allergie
FDA Grants Breakthrough Therapy Designation to DS-8201 americanpharmaceuticalreview
August 30, 2017
FDA has granted Breakthrough Therapy designation to DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), for the treatment of patients with HER2-positive

Previous page 1 2 Next page